Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Nanotubes that heal: Engineering better orthopedic implants

May 19, 2010 10:36 am | by I-Micronews | News | Comments

Titanium and its alloys have a leg up on all other materials used to make the orthopedic implants used by surgeons to repair damaged bones and joints. They are light, super-strong, and virtually inert inside the body. But whether the implants are destined for your knee, your hip, your...

TOPICS:

IGBT modules deliver high power density in compact form

May 19, 2010 10:36 am | by I-Micronews | News | Comments

Infineon Technologies AG is rolling out IGBT modules designed for highest power density and reliability: a PrimePACK module with 1400A in 1700V in a PrimePACK 3 packaging, and the new flagship of the EconoDUAL family, the EconoDUAL 3 with 600A in 1200V.

Nursing and Health launches new master's program

May 19, 2010 10:36 am | by Arizona State University | News | Comments

An academic partnership with the Food and Drug Administration has enabled the launch of a master's degree in regulatory science and health safety, starting fall semester.read more

TOPICS:
Advertisement

Summary Information for: Alair Bronchial Thermoplasty System

May 19, 2010 10:35 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Alair Bronchial Thermoplasty System (P080032).

TOPICS:

APTINA details image sensor pixel technology strategy

May 19, 2010 9:37 am | by I-Micronews | News | Comments

Company enhances Aptina? A-Pix? FSI Technology; Plans roll out of BSI solution

Third generation APTINA? A-PIX? technology enhances mobile imaging solutions

May 19, 2010 9:37 am | by I-Micronews | News | Comments

Company?s advanced pixel technology boosts portfolio with two new 1.4-micron megapixel additions

Stryker Announces Resolution of Two FDA Warning Letters

May 19, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich. , May 19 /- Stryker Corporation (NYSE: SYK ) today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that the actions undertaken to address issues raised in two Warning Letters received in 2007 and 2009 are sufficient.   The Company...

TOPICS:

ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration

May 19, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , May 19 /- ImaginAb, Inc. and the GSK Clinical Imaging Centre (part of the GlaxoSmithKline Group of Companies) have concluded two research collaboration agreements around a clinical therapeutic antibody asset currently under development by GSK in the field of oncology....

TOPICS:
Advertisement

Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment

May 19, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif. , May 19 /- A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010 . The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory...

TOPICS:

Drug in New Class of Targeted Therapies Shows Early Promise Against Blood-Related Cancers

May 19, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

HACKENSACK, N.J. , May 19 /- A Phase I clinical trial of SNS-032, one of the first in a new class of drugs that inhibit cyclin-dependent kinases, demonstrated the drug's safety and potential clinical action against advanced chronic lymphocytic leukemia (CLL). Cyclin-dependent kinases are...

TOPICS:

Clinical Data Demonstrates That LYSTEDA Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB

May 19, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO , May 19 /- Five presentations reporting the results of two placebo-controlled clinical trials evaluating Ferring Pharmaceuticals' LYSTEDAâ„¢ (tranexamic acid) tablets, a novel, first-in-class, non-hormonal therapy indicated for treatment of women with cyclic heavy...

TOPICS:

Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference

May 19, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

RAMSEY, N.J. , May 19 /- Registration is now open for CardioTec, the first and only conference dedicated to addressing the challenges facing the cardiovascular device manufacturing industry. This event, sponsored by Medical Product Outsourcing magazine, invites OEM professionals and...

TOPICS:

Stock sale gain lifts Abiomed to 1Q profit

May 19, 2010 7:10 am | by The Associated Press | News | Comments

Heart device maker Abiomed Inc. on Wednesday reported a return to profitability for the fiscal fourth quarter on the sale of its stake in World Heart Corp., which netted $6.4 million.For the quarter ended March 31, Abiomed said it earned $193,000, or a penny per share, compared with a loss of...

Formation of plexiform lesions in experimental severe pulmonary arterial hypertension

May 19, 2010 6:36 am | by EurekAlert | News | Comments

(American Thoracic Society) A new preclinical model of pulmonary arterial hypertension (PAH) may lead to improved research and ultimately better therapies for this life-threatening problem, according to its developers, researchers at the University of South Alabama.

TOPICS:

At-home sleep testing equal to overnight in a sleep lab in treatment results

May 19, 2010 6:35 am | by EurekAlert | News | Comments

(American Thoracic Society) Patients with suspected obstructive sleep apnea (OSA) may no longer have to spend an expensive and uncomfortable night at a sleep center to monitor their sleep-disordered breathing. According to new research, those who performed sleep testing in their...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading